Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Decheng Capital China Life Sciences USD Fund III, L.P. Create: Alert

All | News | Filings
Date FiledTypeDescription
09/27/2022 4 Decheng Capital China Life Sciences USD Fund III, L.P. (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns: Granted 639,456 shares @ $7.35, valued at $4.7M
Granted 1,360,544 shares @ $7.35, valued at $10M
09/27/2022 SC 13D/A Decheng Capital China Life Sciences USD Fund III, L.P. reports a 17.6% stake in Alpine Immune Sciences, Inc.
09/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/23/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
09/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/21/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/08/2020 SC 13D/A Decheng Capital China Life Sciences USD Fund III, L.P. reports a 13% stake in BeyondSpring Inc.
07/31/2020 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/27/2020 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
02/10/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/23/2019 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/02/2019 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/24/2019 SC 13D Decheng Capital China Life Sciences USD Fund III, L.P. reports a 19.9% stake in Alpine Immune Sciences, Inc.
01/23/2019 3 Decheng Capital China Life Sciences USD Fund III, L.P. (10% Owner) has filed a Form 3 on ALPINE IMMUNE SCIENCES, INC.
04/30/2018 D Form D - Notice of Exempt Offering of Securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy